EUVIMEDEUVIMED entdecken
Crossref

Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World

Houri Esmaeilkhanian, Conrad Dorflinger, Caroline Wang, Philip P Storey, Hasenin Al-Khersan, Kenneth C Fan, Samuel Minaker, Mathew MacCumber, Kevin Quinn, Diana Holcomb, Charles C Wykoff, Edward H Wood

Ophthalmology Retina · 2026-11

DOI: 10.1016/j.oret.2026.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Retina, 2026-11. Verfasst von Houri Esmaeilkhanian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Retina Consultants of America Research; Department of Ophthalmology, Byers Eye Institute, Stanford School of Medicine, Palo Alto, California. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Retina Consultants of America Research; Department of Ophthalmology, Byers Eye Institute, Stanford School of Medicine, Palo Alto, California.
  • Retina Consultants of America Research; University of Tennessee Health Science Center, Memphis, Tennessee.
  • Retina Consultants of America Research; Rush University Medical Center, Chicago, Illinois.
  • Austin Retina Associates, Dell Medical School at The University of Texas at Austin, Austin, Texas.
  • Retina Consultants of Texas, Houston, Texas.
  • Tyler Retina Consultants, Tyler, Texas.

Zitieren

APA

Esmaeilkhanian, H., Dorflinger, C., Wang, C., Storey, P. P., Al-Khersan, H., Fan, K. C., Minaker, S., MacCumber, M., Quinn, K., Holcomb, D., Wykoff, C. C., & Wood, E. H. (2026). Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2026.10.016

Vancouver

Esmaeilkhanian H, Dorflinger C, Wang C, Storey PP, Al-Khersan H, Fan KC, et al. Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World. Ophthalmology Retina. 2026. doi:10.1016/j.oret.2026.10.016

BibTeX
@article{Esmaeilkhanian2026,
  author = {Esmaeilkhanian, Houri and Dorflinger, Conrad and Wang, Caroline and Storey, Philip P and Al-Khersan, Hasenin and Fan, Kenneth C and Minaker, Samuel and MacCumber, Mathew and Quinn, Kevin and Holcomb, Diana and Wykoff, Charles C and Wood, Edward H},
  title = {Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World},
  journal = {Ophthalmology Retina},
  year = {2026},
  doi = {10.1016/j.oret.2026.10.016}
}
Kostenlos starten →